Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Microglial Activation and NET Abnormalities in MS-related Fatigue
NCT04144257Phase 2Completed
- Sponsor
- Brigham and Women's Hospital
- Start
- Mar 2020
- Primary completion
- Apr 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label trial of [18F]PBR06 and 11C-methylreboxetine in multiple sclerosis (MS), sponsored by Brigham and Women's Hospital. Started Mar 2020; status: completed.
02
Drugs
[18F]PBR0611C-methylreboxetine
03
Conditions
multiple sclerosis (MS)
Beyond the preview
Go deeper on NCT04144257.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04144257.